PHELIX THERAPEUTICS
Phelix Therapeutics, LLC is dedicated to saving the lives of people diagnosed with Idiopathic Pulmonary Fibrosis, and other Fibrotic Diseases, by developing innovative treatments for these fatal conditions. Phelix Therapeutics continues to advance and commercialize the Calpain Inhibitor research and development work of Dr. Doron Greenbaum. The unique biological approach of Phelix Therapeutics relies on the insight that the connected processes of cellular injury/death and fibrosis can both be treated by inhibition of a single therapeutic target.
PHELIX THERAPEUTICS
Social Links:
Industry:
Health Care Therapeutics
Founded:
2013-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.phelixtherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
215-966-6232
Email Addresses:
[email protected]
Total Funding:
201.67 K USD
Technology used in webpage:
Nginx DNS.COM Dingfeng Xinhui
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Phelix Therapeutics
Official Site Inspections
http://www.phelixtherapeutics.com
Unable to get host informations!!!
